Ethanol consumption and serotonin-1A (5-HT1A) receptor function in heterozygous BDNF ( plus /-) mice

被引:121
作者
Hensler, JG
Ladenheim, EE
Lyons, WE
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX 78229 USA
[2] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA
关键词
alcohol; S-35]GTP gamma S binding; quantitative autoradiography; two-bottle choice procedure;
D O I
10.1046/j.1471-4159.2003.01748.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heterozygous brain-derived neurotrophic factor (BDNF) (+/-) mice display abnormalities in central serotonergic neurotransmission, develop decrements in serotonergic innervation of the forebrain, and exhibit enhanced intermale aggressiveness. As disturbances of serotonin neurotransmission are implicated in alcohol abuse and aggression, we have examined in BDNF (+/-) mice alcohol drinking behavior, as well as central 5-hydroxytryptamine (5-HT)(1A) receptor function at the level of 5-HT1A receptor-G protein interaction. BDNF (+/-) mice displayed increased ethanol intake in a two-bottle choice procedure. There was no difference in the preference ratio for non-alcoholic tastants (i.e. quinine or saccharin) between genotypes. In the brains of alcohol-naive mice, we measured [(35) S]GTPgammaS binding stimulated by the 5-HT1A receptor agonist (+/-)-8-hydroxy-2-dipropyl-aminotetralin hydrobromide (8-OH-DPAT; 1 mum). In BDNF (+/-) versus wild-type (WT) mice, 5-HT1A receptor-stimulated [(35) S]GTPgammaS binding was significantly attenuated in the median raphe nucleus. There was a decrease in (+/-)8-OH-DPAT-stimulated [(35) S]GTPgammaS binding in the dorsal raphe, which did not reach statistical significance. In the hippocampus, 5-HT1A receptor-stimulated [(35) S]GTPgammaS binding was significantly attenuated in BDNF (+/-) mice. 5-HT1A receptor-stimulated [(35) S]GTPgammaS binding was attenuated in the anterior cingulate cortex and lateral septum, although these reductions did not reach statistical significance. 5-HT1A receptor number was not different between genotypes in any area of brain examined, suggesting that 5-HT1A receptor function, specifically the capacity of the 5-HT1A receptor to activate G proteins, is attenuated in BDNF (+/-) mice.
引用
收藏
页码:1139 / 1147
页数:9
相关论文
共 78 条
[1]  
AGHAJANIAN GK, 1990, ANN NY ACAD SCI, V600, P93
[2]   Brain-derived neurotrophic factor is essential for opiate-induced plasticity of noradrenergic neurons [J].
Akbarian, S ;
Rios, M ;
Liu, RJ ;
Gold, SJ ;
Fong, HF ;
Zeiler, S ;
Coppola, V ;
Tessarollo, L ;
Jones, KR ;
Nestler, EJ ;
Aghajanian, GK ;
Jaenisch, R .
JOURNAL OF NEUROSCIENCE, 2002, 22 (10) :4153-4162
[3]   BRAIN-DERIVED NEUROTROPHIC FACTOR AUGMENTS ROTATIONAL BEHAVIOR AND NIGROSTRIATAL DOPAMINE TURNOVER INVIVO [J].
ALTAR, CA ;
BOYLAN, CB ;
JACKSON, C ;
HERSHENSON, S ;
MILLER, J ;
WIEGAND, SJ ;
LINDSAY, RM ;
HYMAN, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (23) :11347-11351
[4]   THE NEUROTROPHINS NT-4/5 AND BDNF AUGMENT SEROTONIN, DOPAMINE, AND GABAERGIC SYSTEMS DURING BEHAVIORALLY EFFECTIVE INFUSIONS TO THE SUBSTANTIA-NIGRA [J].
ALTAR, CA ;
BOYLAN, CB ;
FRITSCHE, M ;
JACKSON, C ;
HYMAN, C ;
LINDSAY, RM .
EXPERIMENTAL NEUROLOGY, 1994, 130 (01) :31-40
[5]   NEUROENDOCRINE EVIDENCE FOR REDUCED SEROTONERGIC NEUROTRANSMISSION DURING HEAVY DRINKING [J].
BALLDIN, J ;
BERGGREN, U ;
ENGEL, J ;
ERIKSSON, M .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1994, 18 (04) :822-825
[7]   5-HYDROXYINDOLEACETIC ACID IN CEREBROSPINAL-FLUID IN ALCOHOLIC PATIENTS UNDER DIFFERENT CLINICAL CONDITIONS [J].
BORG, S ;
KVANDE, H ;
LILJEBERG, P ;
MOSSBERG, D ;
VALVERIUS, P .
ALCOHOL, 1985, 2 (03) :415-418
[8]   BUSPIRONE IN THE TREATMENT OF ALCOHOLIC PATIENTS [J].
BRUNO, F .
PSYCHOPATHOLOGY, 1989, 22 :49-59
[9]  
De Boer SF, 1999, J PHARMACOL EXP THER, V288, P1125
[10]   ELECTROPHYSIOLOGICALLY-IDENTIFIED SEROTONIN RECEPTORS IN THE RAT CNS - EFFECT OF ANTIDEPRESSANT TREATMENT [J].
DEMONTIGNY, C ;
BLIER, P ;
CHAPUT, Y .
NEUROPHARMACOLOGY, 1984, 23 :1511-1520